Inventor
Peter Kresten Nielsen
Inventor
Holte, DK
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
A61KPreparations for medical, dental or toiletry purposes32%
C07KPeptides27%
C07DHeterocyclic compounds5%
PatentTitleYear
9,963,496Stable glucagon analogues and use for treatment of hypoglycaemia20189,655,974'N-terminal modified FGF21 compounds'20179,486,506'Glucagon analogues'20169,486,505'Glucagon analogues'20169,260,502'Protease-stabilized insulin analogues'20169,018,161'Protease resistant insulin analogues'20158,541,368'Glucagon analogues'20135,354,760'Crystalline Tiagabine monohydrate, its preparation and use'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2018Patents assigned to NOVO NORDISK AS (8)· patent assignee history
1994Based in Herlev, DK· patent location history
2013–2018Based in Holte, DK· patent location history
2015–2017Patents assigned to NIELSEN PETER KRESTEN (3)· patent assignee history
2015–2016Patents assigned to BALSCHMIDT PER (2)· patent assignee history
2015–2016Patents assigned to HUBALEK FRANTISEK (2)· patent assignee history
2015–2016Patents assigned to LAUTRUP-LARSEN INGER (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVO NORDISK AS | 8 | 1994–2018 |
| NIELSEN PETER KRESTENself | 3 | 2015–2017 |
| BALSCHMIDT PER | 2 | 2015–2016 |
| HUBALEK FRANTISEK | 2 | 2015–2016 |
| LAUTRUP-LARSEN INGER | 2 | 2015–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Holte, DK | 7 | 2013–2018 |
| Herlev, DK | 1 | 1994 |